{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:17:39Z","timestamp":1766157459788},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T00:00:00Z","timestamp":1298332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00430-011-0188-z","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T07:43:03Z","timestamp":1298274183000},"page":"165-175","source":"Crossref","is-referenced-by-count":27,"title":["A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice"],"prefix":"10.1007","volume":"200","author":[{"given":"Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xionglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"key":"188_CR1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","volume":"22","author":"LC Rodrigues","year":"1993","unstructured":"Rodrigues LC, Diwan VK, Wheeler JG (1993) Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22:1154\u20131158","journal-title":"Int J Epidemiol"},{"key":"188_CR2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698\u2013702","journal-title":"JAMA"},{"key":"188_CR3","volume-title":"Issues relating to the use of BCG in immunization programmes","author":"PEM Fine","year":"1999","unstructured":"Fine PEM, Carneiro IAM, Milstien JB, Clements CJ (1999) Issues relating to the use of BCG in immunization programmes. WHO, Geneva"},{"key":"188_CR4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","volume":"70","author":"L Brandt","year":"2002","unstructured":"Brandt L, Feino Cunha J, Weinreich Olsen A et al (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70:672\u2013678","journal-title":"Infect Immun"},{"key":"188_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1711.2006.01420.x","volume":"84","author":"SL Fernando","year":"2006","unstructured":"Fernando SL, Britton WJ (2006) Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 84:125\u2013137","journal-title":"Immunol Cell Biol"},{"key":"188_CR6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","volume":"284","author":"MA Behr","year":"1999","unstructured":"Behr MA, Wilson MA, Gill WP et al (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520\u20131523","journal-title":"Science"},{"key":"188_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","volume":"9","author":"AS Leung","year":"2008","unstructured":"Leung AS, Tran V, Wu Z et al (2008) Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC genomics 9:413","journal-title":"BMC genomics"},{"key":"188_CR8","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","volume":"104","author":"R Brosch","year":"2007","unstructured":"Brosch R, Gordon SV, Garnier T et al (2007) Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104:5596\u20135601","journal-title":"Proc Natl Acad Sci USA"},{"key":"188_CR9","doi-asserted-by":"crossref","unstructured":"Carmen Garcia Pelayo M, Uplekar S, Keniry A et al (2009) Comprehensive survey of single nucleotide polymorphisms across Mycobacterium bovis and BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis and BCG. Infect Immun 77(5):2230\u20132238","DOI":"10.1128\/IAI.01099-08"},{"key":"188_CR10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","volume":"17","author":"MA Behr","year":"1999","unstructured":"Behr MA, Small PM (1999) A historical and molecular phylogeny of BCG strains. Vaccine 17:915\u2013922","journal-title":"Vaccine"},{"issue":"1","key":"188_CR11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/345862","volume":"187","author":"KN Lewis","year":"2003","unstructured":"Lewis KN, Liao R, Guinn KM et al (2003) Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Gu\u00e9rin attenuation. J Infect Dis 187(1):117\u2013123","journal-title":"J Infect Dis"},{"issue":"21","key":"188_CR12","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","volume":"100","author":"T Hsu","year":"2003","unstructured":"Hsu T, Hingley-Wilson SM, Chen B et al (2003) The primary mechanism of attenuation of bacillus Calmette-Gu\u00e9rin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 100(21):12420\u201312425","journal-title":"Proc Natl Acad Sci USA"},{"key":"188_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/1045-1056(90)90025-U","volume":"18","author":"M Gheorghiu","year":"1990","unstructured":"Gheorghiu M (1990) The present and future role of BCG vaccine in tuberculosis control. Biologicals 18:135\u2013141","journal-title":"Biologicals"},{"key":"188_CR14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","volume":"2","author":"MA Behr","year":"2002","unstructured":"Behr MA (2002) BCG\u2014different strains, different vaccines? Lancet Infect Dis 2:86\u201392","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"188_CR15","first-page":"35","volume":"5","author":"E Yakuwa","year":"1953","unstructured":"Yakuwa E (1953) Comparative studies on the Japanese and French strain of BCG. Sci Rep Res Inst Tohoku Univ Med 5(1):35\u201346","journal-title":"Sci Rep Res Inst Tohoku Univ Med"},{"issue":"4","key":"188_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0041-3879(88)90051-7","volume":"69","author":"GZ Wang","year":"1988","unstructured":"Wang GZ, Balasubramanian V, Smith DW (1988) The protective and allergenic potency of four BCG substrains in use in China determined in two animal models. Tubercle 69(4):283\u2013291","journal-title":"Tubercle"},{"issue":"5","key":"188_CR17","first-page":"379","volume":"75","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Phalen S, Uchida K et al (2000) Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis. Kekkaku 75(5):379\u2013388","journal-title":"Kekkaku"},{"key":"188_CR18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","volume":"27","author":"MA Horwitz","year":"2009","unstructured":"Horwitz MA, Harth G, Dillon BJ et al (2009) Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis. Vaccine 27:441\u2013445","journal-title":"Vaccine"},{"key":"188_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","volume":"64","author":"MR Lagranderie","year":"1996","unstructured":"Lagranderie MR, Balazuc AM, Deriaud E et al (1996) Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64:1\u20139","journal-title":"Infect Immun"},{"key":"188_CR20","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","volume":"74","author":"AI Castillo-Rodal","year":"2006","unstructured":"Castillo-Rodal AI, Casta\u00f1\u00f3n-Arreola M, Hern\u00e1ndez-Pando R et al (2006) Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis. Infect Immun 74:1718\u20131724","journal-title":"Infect Immun"},{"key":"188_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","volume":"9","author":"AS Pym","year":"2003","unstructured":"Pym AS, Brodin P, Majlessi L et al (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9:533\u2013539","journal-title":"Nat Med"},{"key":"188_CR22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2007.02006.x","volume":"66","author":"X Fan","year":"2007","unstructured":"Fan X, Gao Q, Fu R (2007) DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice. Scand J Immun 66:523\u2013528","journal-title":"Scand J Immun"},{"key":"188_CR23","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1016\/j.vaccine.2007.03.052","volume":"25","author":"AC Maue","year":"2007","unstructured":"Maue AC, Waters WR, Palmer MV et al (2007) An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25:4735\u20134746","journal-title":"Vaccine"},{"key":"188_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clim.2007.07.007","volume":"125","author":"M Kalra","year":"2007","unstructured":"Kalra M, Grover A, Mehta N et al (2007) Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. Clinical Immunol 125:173\u2013183","journal-title":"Clinical Immunol"},{"issue":"5","key":"188_CR25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CVI.00486-08","volume":"16","author":"R Fu","year":"2009","unstructured":"Fu R, Wang C, Shi C et al (2009) An improved whole blood interferon-gamma assay based on the CFP21-MPT64 fusion protein. Clinical Vaccine Immunol 16(5):686\u2013691","journal-title":"Clinical Vaccine Immunol"},{"key":"188_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","volume":"77","author":"RM Horton","year":"1989","unstructured":"Horton RM, Hunt HD, Ho SN et al (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61\u201368","journal-title":"Gene"},{"key":"188_CR27","doi-asserted-by":"crossref","unstructured":"Shi C, Chen L, Chen Z et al (2010) Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 28(32):5237\u20135244","DOI":"10.1016\/j.vaccine.2010.05.063"},{"key":"188_CR28","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","volume":"375","author":"SHE Kaufmann","year":"2010","unstructured":"Kaufmann SHE, Hussey G, Lambert P (2010) New vaccines for tuberculosis. Lancet 375:2110\u20132119","journal-title":"Lancet"},{"key":"188_CR29","unstructured":"WHO\/UNICEF (2010) estimates of national immunization coverage. http:\/\/www.who.int\/immunization_monitoring\/routine\/immunization_coverage\/en\/index4.html . Accessed 12 August 2010"},{"key":"188_CR30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","volume":"193","author":"V Davids","year":"2006","unstructured":"Davids V, Hanekom WA, Mansoor N et al (2006) The effect of bacille Calmette-Gu\u00e9rin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 193:531\u2013536","journal-title":"J Infect Dis"},{"issue":"7","key":"188_CR31","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/IAI.00244-07","volume":"75","author":"B Wu","year":"2007","unstructured":"Wu B, Huang C, Garcia L et al (2007) Unique gene expression profiles in infants vaccinated with different Strains of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Infect Immun 75(7):3658\u20133664","journal-title":"Infect Immun"},{"key":"188_CR32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2009.01.034","volume":"27","author":"M Seki","year":"2009","unstructured":"Seki M, Honda I, Fujita I et al (2009) Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains. Vaccine 27:1710\u20131716","journal-title":"Vaccine"},{"issue":"1","key":"188_CR33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-008-0098-x","volume":"198","author":"J Wang","year":"2009","unstructured":"Wang J, Qie Y, Zhu B et al (2009) Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL\/6 mice. Med Microbiol Immunol 198(1):5\u201311","journal-title":"Med Microbiol Immunol"},{"key":"188_CR34","doi-asserted-by":"crossref","unstructured":"Kozak RA, Alexander DC, Liao R et al (2010) Region of difference 2 contributes to virulence of Mycobacterium tuberculosis. Infect Immun. doi: 10.1128\/IAI.00824-10","DOI":"10.1128\/IAI.00824-10"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-011-0188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-011-0188-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-011-0188-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T19:12:24Z","timestamp":1592334744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-011-0188-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1007\/s00430-011-0188-z","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}